Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Four new trials expand evaluation of Genasense

July 1, 2003

Onyx prioritizes Bay-43-9006 program, discontinues therapeutic virus program

July 1, 2003

New urokinase inhibitors under study at Corvas

July 1, 2003

AstraZeneca claims new IGF-1R modulators with utility in cancer therapy

July 1, 2003

Aventis develops new tubulin polymerization inhibitors

July 1, 2003

Wilex radioimmunotherapy enters clinical evaluation in biliary cancers

July 1, 2003

Introgen and NCI enter CTA for development of Advexin

July 1, 2003

Apoptosis inducers prepared and tested at the Burnham Institute

June 30, 2003

Antitumor epothilones identified by Kosan scientists

June 30, 2003

Lorus selects lead antisense compound to target thioredoxin

June 30, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...